Results 171 to 180 of about 595 (184)

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer, 2017
Kazuki Takada, Masakazu Katsura, Shinkichi Takamori   +2 more
exaly  

EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3

OncoImmunology, 2016
Dong-Wan Kim, Tae Min Kim, Bhumsuk Keam   +2 more
exaly  

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Journal of Thoracic Oncology, 2019
Marc Denis, Jean Louis Pujol, Laurent Greillier   +2 more
exaly  

The influence of programmed cell death ligand 2 (PD-L2) expression on survival outcome and tumor microenvironment in diffuse large B cell lymphoma

Leukemia and Lymphoma, 2020
Narittee Sukswai, Kitsada Wudhikarn, Chantiya Chanswangphuwana   +2 more
exaly  

Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis

Thyroid, 2018
Tao Yang, Tara Roberts, Christina Abdel Shaheed   +2 more
exaly  

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

Frontiers in Immunology, 2018
Yu-Tzu Tai, , Shih-Feng Cho
exaly  

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

Annals of Oncology, 2016
Pavel Babal, Michal Chovanec, M Mego
exaly  

Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study

Tumori, 2012
Yan-Bin Chen
exaly  

Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells

Journal of Allergy and Clinical Immunology, 2016
Jihye Kim, Su-Hyung Park, Song-Ee Kim
exaly  

Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study

Journal of Thoracic Oncology, 2019
Jill Walker, Naiyer A Rizvi, Marietta Scott   +2 more
exaly